Exact Mass: 508.3222
Exact Mass Matches: 508.3222
Found 494 metabolites which its exact mass value is equals to given mass value 508.3222
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2'-Apo-beta-carotenal
2-Apo-beta-carotenal is found in citrus. 2-Apo-beta-carotenal is a trace constituent of Citrus specie Trace constituent of Citrus subspecies 2-Apo-beta-carotenal is found in citrus.
PA(8:0/14:0)
PA(8:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/14:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-12:0)
PA(10:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-12:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-14:0)
PA(8:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-14:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
LysoPG(18:2(9Z,12Z)/0:0)
LysoPG(18:2(9Z,12Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
Contignasterol
20-Hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl laurate
11-Ac-(2alpha, 3beta, 5alpha, 6beta, 9alpha, 11alpha)-Cholest-7-ene-2, 3, 5, 6, 9, 11-hexol
Atrotosterone C
(1R*,2R*,3E,7E,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,7-dien-2,16,18-triol
(1R*,2R*,3E,7E,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol
(3S,5R,6S,9R)-megastigman-3,9-diol 3-O-alpha-L-arabinofuranosyl-(1?6)-b-D-glucopyranoside
(2S,3aS)-5-(1-hydroxy-3-(4-methoxyphenyl)propylidene)-2-(2-hydroxypropan-2-yl)-3a,7-bis(3-methylbut-2-en-1-yl)tetrahydrobenzofuran-4,6(2H,5H)-dione|Flemiphilippinone A
solanolactoside C|solanolide 6-O-beta-D-quinovopyranoside
(3S,5R,6S,9S)-megastigmane-3,9-diol 3-O-beta-D-(6-O-beta-D-apiofuranosyl)glucopyranoside|oblongionoside C
(4E)-1-(2,4-dihydroxyphenyl)-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-5-[4-methylpenta-3-enyl]-6-hydroxylhexa-4-en-1-one|ferulaeone E
(4E)-1-(2,4-dihydroxyphenyl)-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-4-(4-methylpenta-3-enyl)-6-hydroxylhexa-4-en-1-one|ferulaeone F
3t-(4-hydroxy-phenyl)-acrylic acid 1-(6,6-dimethoxy-hexyl)-10,10-dimethoxy-decyl ester
cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-6a-(alpha,alpha-dimethylallyl)-L-Trp)
2,5-Piperazinedione, 3-[[1-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-6-[[2-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-, (3S,6S)_120157
C32H36N4O2_8a,16a-Bis(2-methyl-3-buten-2-yl)-5a,8,8a,13,13a,15a,16,16a-octahydroindolo[3,2:4,5]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-7,15(5H,7aH)-dione
(2E,4E)-1-[(2R,6S,14S,22S,25R)-25-(3,3-dimethyloxiran-2-yl)-15-methyl-1,3,13,15-tetraazaheptacyclo[18.4.1.0²,⁶.0⁶,²².0⁷,¹².0¹⁴,²².0¹⁶,²¹]pentacosa-7,9,11,16(21),17,19-hexaen-3-yl]hexa-2,4-dien-1-one
Ala Lys Lys Tyr
Ala Lys Tyr Lys
Ala Tyr Lys Lys
Phe Lys Lys Ser
Phe Lys Ser Lys
Phe Ser Lys Lys
His Lys Lys Pro
His Lys Pro Lys
His Lys Pro Gln
His Lys Gln Pro
His Pro Lys Lys
His Pro Lys Gln
His Pro Gln Lys
His Gln Lys Pro
His Gln Pro Lys
Ile Ile Thr Tyr
Ile Ile Tyr Thr
Ile Leu Thr Tyr
Ile Leu Tyr Thr
Ile Thr Ile Tyr
Ile Thr Leu Tyr
Ile Thr Tyr Ile
Ile Thr Tyr Leu
Ile Tyr Ile Thr
Ile Tyr Leu Thr
Ile Tyr Thr Ile
Ile Tyr Thr Leu
Lys Ala Lys Tyr
Lys Ala Tyr Lys
Lys Phe Lys Ser
Lys Phe Ser Lys
Lys His Lys Pro
Lys His Pro Lys
Lys His Pro Gln
Lys His Gln Pro
Lys Lys Ala Tyr
Lys Lys Phe Ser
Lys Lys His Pro
Lys Lys Pro His
Lys Lys Ser Phe
Lys Lys Tyr Ala
Lys Pro His Lys
Lys Pro His Gln
Lys Pro Lys His
Lys Pro Gln His
Lys Gln His Pro
Lys Gln Pro His
Lys Ser Phe Lys
Lys Ser Lys Phe
Lys Tyr Ala Lys
Lys Tyr Lys Ala
Leu Ile Thr Tyr
Leu Ile Tyr Thr
Leu Leu Thr Tyr
Leu Leu Tyr Thr
Leu Thr Ile Tyr
Leu Thr Leu Tyr
Leu Thr Tyr Ile
Leu Thr Tyr Leu
Leu Tyr Ile Thr
Leu Tyr Leu Thr
Leu Tyr Thr Ile
Leu Tyr Thr Leu
Pro His Lys Lys
Pro His Lys Gln
Pro His Gln Lys
Pro Lys His Lys
Pro Lys His Gln
Pro Lys Lys His
Pro Lys Gln His
Pro Gln His Lys
Pro Gln Lys His
Gln His Lys Pro
Gln His Pro Lys
Gln Lys His Pro
Gln Lys Pro His
Gln Pro His Lys
Gln Pro Lys His
Ser Phe Lys Lys
Ser Lys Phe Lys
Ser Lys Lys Phe
Thr Ile Ile Tyr
Thr Ile Leu Tyr
Thr Ile Tyr Ile
Thr Ile Tyr Leu
Thr Leu Ile Tyr
Thr Leu Leu Tyr
Thr Leu Tyr Ile
Thr Leu Tyr Leu
Thr Tyr Ile Ile
Thr Tyr Ile Leu
Thr Tyr Leu Ile
Thr Tyr Leu Leu
Tyr Ala Lys Lys
Tyr Ile Ile Thr
Tyr Ile Leu Thr
Tyr Ile Thr Ile
Tyr Ile Thr Leu
Tyr Lys Ala Lys
Tyr Lys Lys Ala
Tyr Leu Ile Thr
Tyr Leu Leu Thr
Tyr Leu Thr Ile
Tyr Leu Thr Leu
Tyr Thr Ile Ile
Tyr Thr Ile Leu
Tyr Thr Leu Ile
Tyr Thr Leu Leu
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 / 26,26,26,27,27,27-hexafluoro-25-hydroxycholecalciferol
3α,7α,12α-trihydroxy-27-carboxymethyl-5β-cholestan-26-oic acid
3alpha,7alpha,12alpha-trihydroxy-27-carboxymethyl-5beta-cholestan-26-oic acid
b-Apo-2'-carotinal
glas#20
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#20 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
ST 28:3;O8
26,26,26,27,27,27-hexafluoro-1alphaa-hydroxyvitamin D3
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3
(2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
3,9-bis(isodecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] hydrogen glutarate
benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate
3,3,3,3-Tetramethyl-5,5,6,6-tetrapropoxy-1,1-spirobiindane
1-O-{(11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoyl}-beta-D-glucopyranose
2-(1,1-Dimethyl-2-propenyl)cyclo[L-Trp-2-(1,1-dimethyl-2-propenyl)-L-Trp-]
(3S)-3alpha-[1-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6alpha-[2-(1,1-dimethyl-2-propenyl)-1H-indole-3-ylmethyl]piperazine-2,5-dione
1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-Hexadecanoyl-2-(5-hydroxypentanoyl)-sn-phosphatidate(2-)
(3R,4R,5R,6R,7R,8R,9S,10R,13R,14R,17R)-3,4,6,7-tetrahydroxy-17-[(1R)-1-[(2R,4R)-6-hydroxy-4-propan-2-yloxan-2-yl]ethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,16,17-tetradecahydrocyclopenta[a]phenanthren-15-one
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
2-[[(2R)-3-[(Z)-heptadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-[(Z)-heptadec-10-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(3-Phosphonooxy-2-undecanoyloxypropyl) undecanoate
2,3-dihydroxypropyl [2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
(2-Acetamido-3-hydroxyoctadecyl) 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(nonanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Dodecanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) nonadecanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate
2-[[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] dodecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] dodecanoate
[1-carboxy-3-[2-hydroxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[2-[(Z)-heptadec-4-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(Z)-heptadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-propanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[3-[3-acetyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[hydroxy-[2-propanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)
[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] 12-methyltridecanoate
[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] tetradecanoate
3alpha,7alpha,12alpha-trihydroxy-27a,27b-dihomo-5beta-cholestane-26,27b-dioic acid
LSM(20:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MCP110
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 blocks the interaction of Ras with Raf. MCP110 disrupts this interaction might can be used for the research of human tumors[1].
2-({3-ethoxy-14-hydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadec-4(8)-en-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(3as,5ar,7r,8s,9ar,11ar)-3a,7,8-trihydroxy-1-[(2r,3r)-6-hydroxy-2,3-dimethoxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1-[25-(3,3-dimethyloxiran-2-yl)-15-methyl-1,3,13,15-tetraazaheptacyclo[18.4.1.0²,⁶.0⁶,²².0⁷,¹².0¹⁴,²².0¹⁶,²¹]pentacosa-7,9,11,16,18,20-hexaen-3-yl]hexa-2,4-dien-1-one
3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol
(3s)-5-{[(1r,3as,4s,12as)-1-[2-(acetyloxy)propan-2-yl]-4-hydroxy-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
3a,7,8,10-tetrahydroxy-1-[3-hydroxy-5-(hydroxymethyl)-5-isopropyl-2-methyloxolan-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
2-{[9-hydroxy-6-isopropyl-14-(methoxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-1,6,13-trien-8-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol
(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-1-[(1r)-1-hydroxy-1-[(2r,3r)-3-(3-hydroxy-3-methylbutan-2-yl)oxiran-2-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butan-2-yl]oxy}oxane-3,4,5-triol
(1s,2s,3as,5as,7s,9as,9br,11as)-1-[(1r)-1-[(2s,3r,4s,5s)-4-ethyl-3-hydroxy-5-(hydroxymethyl)-5-methyloxolan-2-yl]-2-hydroxyethyl]-9a,11a-dimethyl-2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,2,7-triol
(3r)-5-{[(1r,3as,4s,12as)-1-[2-(acetyloxy)propan-2-yl]-4-hydroxy-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
2,3,14,20,22,26-hexahydroxystigmast-7-en-6-one; (2β,3β,5β,20r,22r,24ξ,25ξ)-form
{"Ingredient_id": "HBIN003792","Ingredient_name": "2,3,14,20,22,26-hexahydroxystigmast-7-en-6-one; (2\u03b2,3\u03b2,5\u03b2,20r,22r,24\u03be,25\u03be)-form","Alias": "NA","Ingredient_formula": "C29H48O7","Ingredient_Smile": "NA","Ingredient_weight": "508.69","OB_score": "NA","CAS_id": "20853-88-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9028","PubChem_id": "NA","DrugBank_id": "NA"}
2,3,14,20,22,29-hexahydroxystigmast-7-en-6-one; (2β,3β,5β,20r,22r,24ξ)-form
{"Ingredient_id": "HBIN003793","Ingredient_name": "2,3,14,20,22,29-hexahydroxystigmast-7-en-6-one; (2\u03b2,3\u03b2,5\u03b2,20r,22r,24\u03be)-form","Alias": "NA","Ingredient_formula": "C29H48O7","Ingredient_Smile": "NA","Ingredient_weight": "508.69","OB_score": "NA","CAS_id": "21132-15-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9027","PubChem_id": "NA","DrugBank_id": "NA"}
amarasterone a
{"Ingredient_id": "HBIN015808","Ingredient_name": "amarasterone a","Alias": "NA","Ingredient_formula": "C29H48O7","Ingredient_Smile": "CCC(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(C)CO","Ingredient_weight": "508.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1014","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101297611","DrugBank_id": "NA"}
amarasterone b
{"Ingredient_id": "HBIN015809","Ingredient_name": "amarasterone b","Alias": "NA","Ingredient_formula": "C29H48O7","Ingredient_Smile": "CC(C)C(CCO)CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O","Ingredient_weight": "508.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1015","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101297612","DrugBank_id": "NA"}